FDA inspection
Custom RX LLC, dba Custom RX Compounding Pharmacy: FDA inspection ending Feb 26, 2003
FDA inspection 262631 · No Action Indicated (NAI) · Minneapolis, MN
Key facts
| Inspection ID | 262631 |
|---|---|
| Firm | Custom RX LLC, dba Custom RX Compounding Pharmacy |
| FEI number | 3003316042 |
| Address | 6519 Nicollet Ave |
| City | Minneapolis |
| State | MN |
| ZIP | 55423-1669 |
| Fiscal year | 2003 |
| Inspection end date | Feb 26, 2003 |
| Classification | No Action Indicated (NAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data